CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend

This triple peptide blend combines CJC-1295 (Mod GRF 1-29), Ipamorelin, and GHRP-2 for synergistic GH release via multiple pathways. CJC-1295 activates GHRH receptors with enhanced stability, while Ipamorelin and GHRP-2 activate GHS-R1a (ghrelin receptors) with potential effects on appetite. Research indicates applications in GH deficiency, bone density, and muscle mass studies.